R&D PIPELINE THERAPY AREAS

R&D Pipeline Therapy Areas

The agents and uses mentioned below are investigational and have not been approved by the US Food and Drug Administration (FDA) for the uses under investigation. No conclusions regarding safety and efficacy should be drawn for such agents and uses.
Sanofi’s oncology pipeline strategy is to leverage new technologies empowering molecular oncology, immune-oncology, and genomic medicine platforms with a focus on multiple myeloma (MM) and other blood cancers, as well as lung cancers.

Latest News from Sanofi

New data from Sanofi’s oncology pipeline and portfolio to be presented at ASCO 2023

Educational Resources

General

Pre-approval Information Exchange: Overview of the Sanofi Specialty Care Pipeline
A presentation providing a brief general overview of Sanofi’s specialty care R&D pipeline, including investigational agents and proposed mechanistic targets in Multiple Myeloma. All information is updated quarterly.

Multiple Myeloma

Isa-KRd in GMMG-CONCEPT Trial in High Risk NDMM
Initial results from a Phase 3 study investigating isatuximab in high risk, newly diagnosed multiple myeloma.

IMS 2023 Quach Ph1b OBDS Final Analysis
A presentation of a trial investigating isatuximab in a subcutaneous formulation, administered through an on-body delivery system.

IMS 2023 O'Donnell Isa-KRD in NDMM SKylaRk ISS
An overview of the Phase 2 SKYLAARK Trial of isatuximab in combination with KRd in newly diagnosed multiple myeloma.

Pre-approval Information Exchange: Addition of Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone as Induction Therapy for Newly Diagnosed, Transplant-Eligible Multiple Myeloma: The Phase 3 GMMG-HD7 Trial
A presentation summarizing the study design and efficacy and safety results from the Phase 3 GMMG-HD7 study of isatuximab versus isatuximab plus RVd in patients with newly diagnosed, transplant-eligible MM. These data were presented at the 2021 American Society of Hematology (ASH) Annual Meeting and Exposition.

GMMG-HD7: NCT03617731; Link to Publication